The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Melatonin Prevents Death of Neuroblastoma Cells Exposed to the Alzheimer Amyloid Peptide
Open accessAbstract
Studies from several laboratories have generated evidence suggesting that oxidative stress is involved in the pathogenesis of Alzheimer's disease (AD). The finding that the amyloid beta protein (Abeta) has neurotoxic properties and that such effects are, in part, mediated by free radicals has provided insights into mechanisms of cell death in AD and an avenue to explore new therapeutic approaches. In this study we demonstrate that melatonin, a pineal hormone with recently established antioxidant properties, is remarkably effective in preventing death of cultured neuroblastoma cells as well as oxidative damage and intracellular Ca2+ increases induced by a cytotoxic fragment of Abeta. The effects of melatonin were extremely reproducible and corroborated by multiple quantitative methods, including cell viability studies by confocal laser microscopy, electron microscopy, and measurements of intracellular calcium levels. The importance of this finding is that, in contrast to conventional antioxidants, melatonin has a proposed physiological role in the aging process. Secretion levels of this hormone are decreased in aging and more severely reduced in AD. The reported phenomenon may be of therapeutic relevance in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies have also reported that antioxidants protect against Aβ induced neuronal toxicity [16,17].”
From Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment (2020) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vermes, I., Haanen, C., Steffens-Nakken, H. M., & Reutellingsperger, C. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00072-i · Cited by 5,509
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Koopman, G., Reutelingsperger, C. P. M., Kuijten, G., Keehnen, R. M. J., Pals, S. T., & van Oers, M. H. J. (1994) · Blood · doi:10.1182/blood.v84.5.1415.1415 · Cited by 2,687
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Koopman, G., Reutelingsperger, C., Kuijten, G., et al. (1994) · Blood · doi:10.1182/blood.v84.5.1415.bloodjournal8451415 · Cited by 2,068
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 1×
“Ab also is produced during normal cellular metabolism (Haass et al., 1992; Shoji et al., 1992).”
BackgroundMattson, M. P., Cheng, B., Davis, D. G., Bryant, K., Lieberburg, I. M., & Rydel, R. E. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,633 · cited 1×
“In addition to free radicals, increased sensitivity to excitotoxicity (Copani et al., 1995) and /or disruption of Ca 2ϩ homeostasis (Mattson et al., 1992, 1993; Le et al., 1995; Mark et al., 1995) seem to be involved.”
BackgroundFluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores
Minta, A., Kao, J. P. Y., & Tsien, R. Y. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83165-9 · Cited by 1,621 · cited 2×
“The fluorescent probe fluo-3 was used for measurements of Ca(21) as described (Minta et al., 1985).”
Method
Research works printed but not linked: 1
- Hyman BT West HL Gomez-Isla T Mui S (1985) Quantitative neuropathology in Alzheimer’s disease: neuronal loss in high-order association cortex parallels dementia. in Research advances in Alzheimer’s disease and related disorders, eds Iqbal K Mortimer JA Windblad B Wisniewski HM (Wiley, New York), pp 453–460.
Cited by
Sorted by citations
Items 101–200 of 357
Neuroprotection: Targeting Multiple Pathways by Naturally Occurring Phytochemicals
Khan, A., Jahan, S., Imtiyaz, Z., Alshahrani, S., Makeen, H. A., Alshehri, B., Kumar, A., Arafah, A. M., & Rehman, M. U. (2020) · Biomedicines · doi:10.3390/biomedicines8080284 · Cited by 93
Melatonin Relieves the Neural Oxidative Burden that Contributes to Dementias
Reiter, R. J., Tan, D. X., & Pappolla, M. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.012 · Cited by 89
Alzheimer β protein mediated oxidative damage of mitochondrial DNA: Prevention by melatonin
Pappolla, M. A., Chyan, Y., Pöeggeler, B., Bozner, P., Ghiso, J. A., LeDoux, S. P., & Wilson, G. L. (1999) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1999.tb00619.x · Cited by 89
Indole derivatives as neuroprotectants
Štolc, S. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00453-1 · Cited by 89
Aging, circadian rhythms and depressive disorders: a review.
Costa, I. C., Carvalho, H. N., & Fernandes, L. P. N. S. (2013) · Europe PMC (PubMed Central) · Cited by 90
Shukla, M., Htoo, H. H., Wintachai, P., Hernandez, J., Dubois, C. M., Postina, R., Xu, H., Checler, F., Smith, D. R., Govitrapong, P., et al. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12200 · Cited by 88
“Ab-induced apoptosis [18] and improves learning and memory deficits as observed in a transgenic mouse model of AD [19].”
BackgroundMas, A., Guillamón, J. M., Torija, M.-J., Beltran, G., Cerezo, A. B., Troncoso, A. M., & García-Parrilla, M. C. (2014) · BioMed Research International · doi:10.1155/2014/898045 · Cited by 88
“However, most of its effects suggest a clear neurohormonal activity, which has allowed us to relate their presence to learning and memory processes [39], ageing, and treatment for Alzheimer’s disease [40, 41], amyotrophic lateral sclerosis [42], or migraine [43].”
BackgroundWang, Y., Wang, H., & Chen, H. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160119094820 · Cited by 87
“It has been reported that melatonin possesses strong antioxidant properties with a direct scavenging function on a variety of ROS, exhibits protective effects against Aβ-induced apoptosis in microglia and improves learning and memory in AD model rats [57-59].”
The Use of Chronobiotics in the Resynchronization of the Sleep–wake Cycle
Cardinali, D. P., Furio, A. M., Reyes, M. P., & Brusco, L. I. (2006) · Cancer Causes & Control · doi:10.1007/s10552-005-9009-2 · Cited by 86
“In addition, in vitro experiments indicated that melatonin protects neurons against b-amyloid toxicity [66], prevents b-amyloid-induced lipid peroxidation [67] and alters the metabolism of the b-amyloid precursor protein [68].”
Anti-Amyloidogenic and Anti-Apoptotic Role of Melatonin in Alzheimer Disease
He, H., Dong, W., & Huang, F. P. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246137 · Cited by 83
“In vitro experiments showed that A -treated cultures exhibited characteristic features of apoptosis, and melatonin attenuated A -induced apoptosis in a number of cellular models of AD including hippocampal neurons, PC12 cells, mouse microglial BV2 cells and rat astroglioma C6 cells [22, 23, 38, 74, 94].”
Activation of melatonin signaling promotes β-cell survival and function
Costes, S., Boss, M., Thomas, A. P., & Matveyenko, A. V. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1293 · Cited by 84
Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis
Pappolla, M. A., Matsubara, E., Vidal, R., Pacheco‐Quinto, J., Pöeggeler, B., Zagorski, M. G., & Sambamurti, K. (2018) · Current Alzheimer Research · doi:10.2174/1567205015666180411092551 · Cited by 83
“Pineal and retinal melatonin is involved in circadian rhythm regulation, and has several physiological functions including vascular actions, antioxidative and neuroprotective properties (39, 40).”
BackgroundTeixeira, A., Morfim, M. P., de Cordova, C. A. S., Charão, C. C. T., de Lima, V. R., & Creczynski‐Pasa, T. B. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00085.x · Cited by 84
Melatonin prevents β‐amyloid‐induced lipid peroxidation
Daniels, W. M. U., van Rensburg, S. J., van Zyl, J. M., & Taljaard, J. J. F. (1998) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1998.tb00370.x · Cited by 84
Melatonin affects the metabolism of the β‐amyloid precursor protein in different cell types
Lahiri, D. K. (1999) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1999.tb00575.x · Cited by 83
Rudnitskaya, E. A., Muraleva, N. A., Maksimova, K. Y., Владимировна, К. Е., Kolosova, N. G., & Stefanova, N. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150161 · Cited by 82
“As for AD, studies showed that melatonin can cleavage of the amyloid-(cid:1) protein precursor) [18] aggregation of A (cid:1) , and formation of (cid:1) -sheets and fib-rils [19, 20], and reduce oxidative damage induced by A (cid:1) [21], thereby protecting from neurotoxicity [18 22, 23].”
Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures
Beffert, U., Aumont, N., Dea, D., Lussier‐Cacan, S., Davignon, J., & Poirier, J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00073-x · Cited by 81
Skaper, S. D., Ancona, B., Facci, L., Franceschini, D., & Giusti, P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.9.725 · Cited by 80
“Most studies have used pharmacological concentrations of melatonin to protect against free radical damage, although physiological levels of the indole have been shown to be beneficial in preventing the death of neuroblastoma cells exposed to the Alzheimer amyloid peptide (52).”
BackgroundRı́os, C. D. L., Egea, J., Marco, J. L., Leon, R. M., Samadi, A., Iriepa, I., Moraleda, I., Galvez‐Ruano, E., Garcı́a, A. G., López, M. G., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901902w · Cited by 79
Effect of Melatonin in Selected Populations of Sleep-Disturbed Patients
Brusco, L., Fainstein, I., Márquez, M., & Cardinali, D. P. (1999) · Neurosignals · doi:10.1159/000014580 · Cited by 79
Study on the neuroprotective effects of Genistein on Alzheimer’s disease
Duan, X., Li, Y., Xu, F., & Ding, H. (2021) · Brain and Behavior · doi:10.1002/brb3.2100 · Cited by 78
“The receptors combine with ApoE and ingest Aβ, thus reducing the extracellular level of Aβ and reducing nerve injury (Pappolla et al., 1997).”
BackgroundMelatonin oxidative stress and neurodegenerative diseases.
Srinivasan, V. (2002) · PubMed · Cited by 78
Melatonin improves quality and longevity of chronic neural recording
Golabchi, A., Wu, B., Li, X., Carlisle, D. L., Kozai, T. D. Y., Friedlander, R. M., & Cui, X. T. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.026 · Cited by 74
“Several studies have demonstrated the protective role of MT as an antioxidant in reducing apoptosis both in vivo and in vitro [44-48].”
Melatonin prevents hydrogen peroxide‐induced Bax expression in cultured rat astrocytes
Juknat, A., Méndez, M. D. V. A., Quaglino, A., Fameli, C. I., Mena, M., & Kotler, M. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00166.x · Cited by 81
“Finally, it has been shown that melatonin prevents neuronal apoptosis in different experimental conditions, at both pharmacological [23, 25, 42] and physiological concentrations [24].”
BackgroundSong, W., & Lahiri, D. K. (1997) · Journal of Molecular Neuroscience · doi:10.1007/bf02736852 · Cited by 78
Effects of Exogenous Melatonin - A Review
Anisimov, V. N. (2003) · Toxicologic Pathology · doi:10.1080/01926230390257885 · Cited by 76
Montilla-López, P., Muñoz-Águeda, M. C., Feijóo, M., Muñoz-Castañeda, J. R., Bujalance, I., & Túnez‐Fiñana, I. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02151-9 · Cited by 76
Dies, H., Toppozini, L., & Rheinstadter, M. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099124 · Cited by 74
“Conversely, melatonin, a pineal hormone involved in regulating the circadian cycle, has been shown to have the opposite effect; it acts as an antioxidant and may also inhibit the formation of toxic amyloid structures [26].”
Backgroundβ-Amyloid Production, Aggregation, and Clearance as Targets for Therapy in Alzheimer's Disease
Felice, F. G. D., & Ferreira, S. T. (2002) · Cellular and Molecular Neurobiology · doi:10.1023/a:1021832302524 · Cited by 75
“Several studies have shown that the pineal hormone, melatonin, interacts with Aβ, inhibiting fibrillogenesis (Pappolla et al., 1998) and preventing cellular death in culture, oxidative damage, and the increase in intracellular Ca2+ induced by Aβ (Pappolla et al., 1997).”
BackgroundLi, L., Wei, L. I., Jung, S., Lee, Y., & Kim, Y.-H. (2011) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.100606 · Cited by 73
Cell Culture Models of Oxidative Stress and Injury in the Central Nervous System
Aksenova, M. V., Aksenov, M. Y., Mactutus, C. F., & Booze, R. M. (2005) · Current Neurovascular Research · doi:10.2174/1567202052773463 · Cited by 73
“The ability of different antioxidants to protect neurons in culture against amyloid beta-peptide toxicity has been intensively investigated (Butterfield et al., 1999b; Yatin et al., 2000; Sultana et al., 2004; Behl et al., 1997; Goodman et al., 1994; 1996; Pappolla et al., 1997).”
Melatonin suppresses iron-induced neurodegeneration in rat brain
Lin, A. M.-Y., & Ho, L. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00169-6 · Cited by 72
Neuronal plasticity and stressor toxicity during aging
Brewer, G. J. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00121-2 · Cited by 71
“Melatonin (10 mM) prevents death of neuroblastoma cells exposed to b-amyloid, reduces lipid peroxidation and eliminates the rise in intracellular calcium (Pappolla et al., 1997), as well as preventing oxidative damage to DNA (Pappolla et al.”
BackgroundBalmik, A. A., & Chinnathambi, S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170900 · Cited by 69
“Studies were carried out on A (cid:2) aggregation in the presence or absence of melatonintoobserveitseffectonaggregationpropen-sityandstructuralchange[63].”
Swarnakar, S., Mishra, A., Ganguly, K., & Sharma, A. V. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00443.x · Cited by 69
“It also reduces age-related oxidative damage in the central nervous system [24], Alzheimer’s disease [25], Parkinson’s disease [26] etc.”
BackgroundInvolvement of reactive oxygen species in gastric ulceration: protection by melatonin.
Bandyopadhyay, D., Biswas, K., Bhattacharyya, M., Reiter, R. J., & Banerjee, R. K. (2002) · PubMed · Cited by 69
Effect of melatonin on calyculin A-induced tau hyperphosphorylation
Li, X., Wang, X., Zhang, J., Wang, Q., & Wang, J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.023 · Cited by 68
Melatonin reduces amyloid β‐induced apoptosis in pheochromocytoma (PC12) cells
Feng, Z., & Zhang, J. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00164.x · Cited by 68
“Antioxidants also have been reported to protect neurons from Ab-induced neurotoxicity [29, 30].”
BackgroundBenítez‐King, G. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00085-2 · Cited by 66
Roy, J., Wong, K. Y., Aquili, L., Uddin, M. S., Heng, B. C., Tipoe, G. L., Wong, K.-H., Fung, M., & Lim, L. W. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.100986 · Cited by 64
Quirós-González, I., Mayo, J. C., García‐Suárez, O., Hevia, D., Martı́n, V., Rodrı́guez, C., & Sainz, R. M. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.02.009 · Cited by 66
Esteban, S., Garau, C., Aparicio, S., Moranta, D., Barceló, P., Fiol-deRoque, M. A., & Rial, R. V. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00741.x · Cited by 64
Ethyl ether fraction of Gastrodia elata Blume protects amyloid β peptide-induced cell death
Kim, H.-J., Moon, K., Lee, D., & Lee, S. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00290-8 · Cited by 63
Cytoprotective properties of melatonin: presumed association with oxidative damage and aging
Reiter, R. J. (1998) · Nutrition · doi:10.1016/s0899-9007(98)00064-1 · Cited by 63
Spinedi, E., & Cardinali, D. P. (2018) · Neuroendocrinology · doi:10.1159/000494889 · Cited by 64
Zatta, P. F., Tognon, G., & Carampin, P. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00058.x · Cited by 64
“[41, 63] and only recently partially described [30].”
Several antioxidant pathways are involved in astrocyte protection by melatonin
Martı́n, V., Sainz, R. M., Antolı́n, I., Mayo, J. C., Herrera, F., & Rodrı́guez, C. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.02113.x · Cited by 63
“This effect has been shown at both pharmacological [9, 10] and physiological concentrations [3].”
BackgroundMelatonin delays photoreceptor degeneration in the rds/rds mouse
Liang, F.-Q., Alemán, T. S., Yang, Z., Cideciyan, A. V., Jacobson, S. G., & Bennett, J. (2001) · Neuroreport · doi:10.1097/00001756-200104170-00029 · Cited by 62
Skribanek, Z., Baláspiri, L., & Mák, M. (2001) · Journal of Mass Spectrometry · doi:10.1002/jms.243 · Cited by 62
Inestrosa, N. C., Carvajal, F. J., Zolezzi, J. M., Tapia‐Rojas, C., Serrano, F. G., Karmelic, D., Toledo, E. M., Toro, A., Toro, J., & Santos, M. J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120397 · Cited by 62
The Role of Mitochondria in Brain Aging and the Effects of Melatonin
Escames, G., López, A., Garcia, J. A. D., Garcia, L., Acuña-Castroviejo, D., Garcia, J. J., & López, L. C. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246245 · Cited by 62
“When neuroblastoma cells were incubated with A , more than 80% of the neurons died due to apoptosis, but the presence of melatonin reduced cellular death and DNA damage in a dose-related manner [124].”
BackgroundThe organization of melatonin in lipid membranes
Dies, H., Cheung, B. S., Tang, J., & Rheinstadter, M. C. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.01.006 · Cited by 61
Ganguly, K., Maity, P., Reiter, R. J., & Swarnakar, S. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2005.00250.x · Cited by 61
“Melatonin also reduces age-related oxidative damage in the central nervous system [25], Alzheimer’s disease [26], Parkinson’s disease [27], etc.”
BackgroundMelatonin and Colon Carcinogenesis
Anisimov, V. N. (2001) · Springer eBooks · doi:10.1007/978-3-642-59512-7_11 · Cited by 61
The Neurobiology and Pharmacotherapy of Alzheimer's Disease
Félician, O., & Sandson, T. A. (1999) · Journal of Neuropsychiatry · doi:10.1176/jnp.11.1.19 · Cited by 61
Membrane-Accelerated Amyloid-β Aggregation and Formation of Cross-β Sheets
Khondker, A., Alsop, R. J., & Rheinstadter, M. C. (2017) · Membranes · doi:10.3390/membranes7030049 · Cited by 58
Sleep and circadian rhythm disruption and stress intersect in Alzheimer's disease
Phan, T., & Malkani, R. G. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.10.001 · Cited by 66
Medina, S., Martı́nez, M., & Hernánz, Á. (2002) · Free Radical Research · doi:10.1080/107157602100006445 · Cited by 60
Alzheimer’s Disease and Antioxidant Therapy: How Long How Far?
Teixeira, J., Silva, T., Andrade, P. B., & Borges, F. (2013) · Current Medicinal Chemistry · doi:10.2174/1871523011320240001 · Cited by 59
“It has been demonstrated that it has neuroprotective and antioxidant properties against A mediated oxidative injury in vitro [73].”
BackgroundYasui, E., Wada, M., & Takamura, N. (2005) · Tetrahedron Letters · doi:10.1016/j.tetlet.2005.11.126 · Cited by 59
N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine is a product of melatonin oxidation in rats
Rozov, S. V., Филатова, Е. В., Orlov, A. A., Volkova, A. V., Zhloba, A. R. A., Блашко, Э. Л., & Pozdeyev, N. V. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00081.x · Cited by 58
“Melatonin used at pharmacological doses has been shown to be effective against free radical damage in models of Alzheimer disease [6, 7], Parkinson’s disease [8–10], excitotoxicity [11, 12], porphyric neuropathy [13, 14], hyperoxia [15] as well as in newborn infants with sepsis [16] or suffering from transient asphyxi…”
BackgroundApoptosis, Neurotrophic Factors and Neurodegeneration
Dragunow, M., MacGibbon, G. A., Lawlor, P. A., Butterworth, N. J., Connor, B. J., Henderson, C. E., Walton, M. R., Woodgate, A.-M., Hughes, P. E., & Faull, R. L. M. (1997) · Reviews in the Neurosciences · doi:10.1515/revneuro.1997.8.3-4.223 · Cited by 58
Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells
Armstrong, K. J., & Niles, L. P. (2002) · Neuroreport · doi:10.1097/00001756-200203250-00023 · Cited by 57
Marzia Perluigi, A., Gururaj Joshi, A., Rukhsana Sultana, A., Calabrese, V., Marco, C. D., Coccia, R., & Butterfield, D. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.004 · Cited by 57
Antioxidant strategies in protection against neurodegenerative disorders
Tan, D.-X., Manchester, L. C., Sainz, R. M., Mayo, J. C., Alvares, F. L., & Reiter, R. J. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.10.1513 · Cited by 57
Melatonin blocks rat hippocampal neuronal apoptosis induced by amyloid beta‐peptide 25–35
Shen, Y., Xu, S., Wei, W., Wang, X., Wang, H., & Sun, X. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.1o839.x · Cited by 58
“The ability of melatonin to protect against Ab-induced apoptosis may also relate to the antioxidant actions of melatonin as suggested by Pappolla et al. (1997).”
BackgroundVincent, B. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.011 · Cited by 56
“A chronological review of the studies carried out in this field brings us twenty years back when Pappolla and colleagues showed for the first time that melatonin (5 to 50μM for 12–24 hours) was able to prevent Aβ 25-35 and Aβ40-induced cell death, oxidative stress and intracellular calcium increases in rat PC12 pheoch…”
BackgroundRole of melatonin supplementation in neurodegenerative disorders
Polimeni, G. (2014) · Frontiers in bioscience · doi:10.2741/4217 · Cited by 57
Mechanism of neuroprotection of melatonin against beta-amyloid neurotoxicity
Йонов, М., Burchell, V., Klajnert‐Maculewicz, B., Bryszewska, M. J., & Abramov, A. Y. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.045 · Cited by 55
Harms, C., Lautenschlager, M. M., Bergk, A., Freyer, D., Weih, M., Dirnagl, U., Weber, J. R., & Hörtnagl, H. (2000) · The FASEB Journal · doi:10.1096/fj.99-0899com · Cited by 55
“Furthermore, melatonin protects against glutamate-induced cell death in the clonal hippocampal cell line HT22 (11), prevents delayed neuronal death induced by enhanced excitatory transmission in hippocampal pyramidal neurons in culture (12), and rescues neuroblastoma cells exposed to toxic fragments of Alzheimer’s b-a…”
Bubenik, G. A., Ayles, H. L., Friendship, R. M., Brown, G. M., & Ball, R. O. (1998) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1998.tb00367.x · Cited by 55
Melatonin uptake in prostate cancer cells: intracellular transport versus simple passive diffusion
Hevia, D., Sainz, R. M., Blanco, D., Quirós-González, I., Tan, D. X., Rodrı́guez, C., & Mayo, J. C. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00581.x · Cited by 54
“Thus, melatonin protects bamyloid-induced neuroblastoma cell death [11] by reducing oxidative damage at the mitochondrial level [16].”
BackgroundБачурин, С. О., Oxenkrug, G. F., Lermontova, N., Afanasiev, A. V., Beznosko, B. K., Van’kin, G. I., Shevtzova, E. F., Mukhina, T. V., & Serkova, T. P. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07990.x · Cited by 54
Brain washing and neural health: role of age, sleep, and the cerebrospinal fluid melatonin rhythm
Reiter, R. J., Sharma, R., Cucielo, M. S., Tan, D. X., Rosales‐Corral, S., Gancitano, G., & Chuffa, L. G. D. A. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04736-5 · Cited by 55
“Cell and transgenic rodent models of AD have provided clues of the possible mechanisms by which melatonin limits AD pathophysiology [87, 88].”
BackgroundNeuroprotection against Aβ and glutamate toxicity by melatonin: Are GABA receptors involved?
Paula-Lima, A. C., Louzada, P. R., Mello, F. G. D., & Ferreira, S. T. (2003) · Neurotoxicity Research · doi:10.1007/bf03033152 · Cited by 53
“Neuroprotective effects of melatonin against Aβ-induced toxicity have also been reported, and the mechanism of protection has been linked to the antioxidant and anti-amyloidogenic properties of this hormone ( Pappolla et al., 1997; 1998 ).”
BackgroundMelatonin and colon carcinogenesis
Anisimov, V. N., Popovich, I. G., Shtylik, A. V., Zabezhinski, M. A., Ben-Huh, H., Gurevich, P., Berman, V., Tendler, Y., & Zusman, I. (2000) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(00)80022-6 · Cited by 53
Melatonin and Its Agonist Ramelteon in Alzheimer′s Disease: Possible Therapeutic Value
Srinivasan, V., Kaur, C., Pandi-Perumal, S. R., Brown, G. M., & Cardinali, D. P. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/741974 · Cited by 53
Muñoz, F. J., Opazo, C., Gil‐Gómez, G., Tapia, G., Fernández, V., Valverde, M. A., & Inestrosa, N. C. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03081.2002 · Cited by 52
“In accordance with the oxidative pathophysiological hypothesis, vitamin E (vit E) and other antioxidants have demonstrated protective properties on neuronal cells against the A-mediated neurotoxicity (Behl et al., 1992; Pappolla et al., 1997 ).”
BackgroundInfluentialAging and oxygen toxicity: Relation to changes in melatonin
Reiter, R. J. (1997) · AGE · doi:10.1007/s11357-997-0020-2 · Cited by 52
Davanipour, Z., & Sobel, E. L. (2009) · Pathophysiology · doi:10.1016/j.pathophys.2009.01.005 · Cited by 50
Protective role of melatonin in domoic acid‐induced neuronal damage in the hippocampus of adult rats
Ananth, C. V., Gopalakrishnakone, P., & Kaur, C. (2003) · Hippocampus · doi:10.1002/hipo.10090 · Cited by 50
Ancelin, M., Christen, Y., & Ritchie, K. A. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000102567 · Cited by 50
Neuroprotection by Melatonin on Astrocytoma Cell Death
Radogna, F., Nuccitelli, S., Mengoni, F., & Ghibelli, L. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04900.x · Cited by 39
Li, S. P., Deng, Y., Wang, X. C., Wang, Y. P., & Wang, J. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00116.x · Cited by 48
Joo, J., Uz, T., & Manev, H. (1998) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-1998-00065 · Cited by 46
“[10,11,15–18,23,30,32,35,50,51], amyloid peptide [6,38,39], 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [3], L-cysteine [55], cyanide [56], or d-aminolevulinic acid [41].”
Protective melatonin effect on oxidative stress induced by okadaic acid into rat brain
Túnez, I., Muñoz, M. D. C., Feijóo, M., Muñoz-Castañeda, J. R., Bujalance, I., Valdelvira, M. E., & López, P. M. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00039.x · Cited by 45
“Furthermore, the degree of Ab-induced lipid peroxidation in the cells was reduced in presence of melatonin [22].”
BackgroundHomer2 and Homer3 interact with amyloid precursor protein and inhibit Aβ production
Parisiadou, L., Bethani, I., Michaki, V., Krousti, K., Rapti, G., & Efthimiopoulos, S. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.004 · Cited by 43
Neuroprotective Effect of Melatonin on Cortical Impact Injury in the Rat
Sarrafzadeh, A. S., Thomale, U. W., Kroppenstedt, S. N., & Unterberg, A. W. (2000) · Acta Neurochirurgica · doi:10.1007/s007010070028 · Cited by 44
“Several in vitro and in vivo studies have confirmed the protective actions of melatonin in neuronal tissue [13, 14, 15, 18 ] and reducing neuronal deficits [16].”
ResultAdenosine Triphosphate (ATP) Reduces Amyloid-β Protein Misfolding in vitro
Coskuner‐Weber, O., & Murray, I. V. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132300 · Cited by 44
Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases
Bonferoni, M. C., Rassu, G., Gavini, E., Sorrenti, M., Catenacci, L., & Giunchedi, P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121246 · Cited by 44
“Several works reported that melatonin has neuroprotective and antioxidant properties against oxidative injury mediated by amyloid β-protein in vitro [86].”
BackgroundSeneff, S., Swanson, N., & Li, C. (2015) · Agricultural Sciences · doi:10.4236/as.2015.61005 · Cited by 43
“Furthermore, researchers have used several different methods to confirm that melatonin protects cultured cells from death following exposure to toxic fragments of amyloid-β [182], another hallmark of Alzheimer’s disease.”
BackgroundJaiswal, M. K. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00295 · Cited by 41
Amyloid β oligomers inhibit growth of human cancer cells
Pavliukevičienė, B., Zentelytė, A., Jankunec, M., Valiulienė, G., Talaikis, M., Navakauskienė, R., Niaura, G., & Valinčius, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221563 · Cited by 42
Pöeggeler, B., Durand, G., Polidori, A., Pappolla, M. A., Vega‐Naredo, I., Coto‐Montes, A. M., Böker, J., Hardeland, R., & Pucci, B. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03425.x · Cited by 41
Alterations in circadian rhythms of melatonin and cortisol in patients with bronchial asthma.
Fei, G., Liu, R., Zhang, Z., & Zhou, J. (2004) · PubMed · Cited by 41
A glycine zipper motif mediates the formation of toxic β-amyloid oligomers in vitro and in vivo
Fonte, V. G., Dostal, V., Roberts, C. M., Gonzales, P. K., Lacor, P. N., Magrané, J., Dingwell, N., Fan, E. Y., Silverman, M. A., Stein, G. H., et al. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-61 · Cited by 37
“Synthetic Ab is toxic in both neuronal cell lines [2,3] and primary neurons [4], and Alzheimer’s-like pathology has been observed in a range of transgenic models that accumulate Ab [5-8].”
BackgroundLahiri, D. K., Chen, D., Lahiri, P., BONDY, S., & Greig, N. H. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1352.008 · Cited by 39
Bazoti, F. N., Tsarbopoulos, A., Markides, K. E., & Bergquist, J. (2005) · Journal of Mass Spectrometry · doi:10.1002/jms.738 · Cited by 38
Coughlan, C. M. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00036-x · Cited by 39
Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases
Trotti, L. M., & Karroum, E. G. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0664-3 · Cited by 38
Metadata
- Authors
- Pappolla, M. A., Sos, M., Omar, R. A., Bick, R. J., Hickson-Bick, D. L. M., Reiter, R. J., Efthimiopoulos, S., & Robakis, N. K.
- Affiliations
- University of South Alabama (US)
- The University of Texas Health Science Center at Houston (US)
- University of Louisville (US)
- The University of Texas at San Antonio Health Science Center (US)
- Icahn School of Medicine at Mount Sinai (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1997-03-01
- Volume
- 17
- Issue
- 5
- Pages
- 1683-1690
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6573387
- OpenAlex
- W2137034584
- Cited by
- 359
- References
- 63
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 9 · 2019: 6 · 2018: 12 · 2017: 5 · 2016: 9 · 2015: 7 · 2014: 16 · 2013: 15 · 2012: 14
- FWCI
- 8.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag011130-03)
- National Institute on Aging (RF1AG008200, R56AG008200, AG-08200, AG-11130, R01AG008200)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- melatonin, Alzheimer's disease, amyloid-beta, neuroblastoma cells, oxidative stress, neurotoxicity, cell death, intracellular calcium, aging, pineal hormone
- MeSH terms
- Alzheimer Disease, Animals, Antioxidants, Calcium, Ditiocarb, Doxorubicin, Melatonin, Neuroblastoma, Neurons, Peptide Fragments, Peptides, Superoxide Dismutase, Reproducibility of Results, Lipid Peroxidation, Amyloid beta-Peptides, PC12 Cells, Apoptosis, Oxidative Stress, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review